Paul E. Van Schil

9.3k total citations · 2 hit papers
68 papers, 2.7k citations indexed

About

Paul E. Van Schil is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Paul E. Van Schil has authored 68 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 11 papers in Internal Medicine. Recurrent topics in Paul E. Van Schil's work include Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (13 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Paul E. Van Schil is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (13 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Paul E. Van Schil collaborates with scholars based in Belgium, Netherlands and United Kingdom. Paul E. Van Schil's co-authors include Solange Peters, Keith M. Kerr, Corinne Faivre‐Finn, Egbert F. Smit, Martin Reck, Tony Mok, Matthew D. Hellmann, David Planchard, Sanjay Popat and Silvia Novello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Paul E. Van Schil

64 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2018 1.6k citations Paul E. Van Schil, Solange Peters et al. Annals of Oncology profile →
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2015 286 citations Paul Baas, Paul E. Van Schil et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Paul E. Van Schil

Since Specialization

Citations

This map shows the geographic impact of Paul E. Van Schil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Van Schil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Van Schil more than expected).

Fields of papers citing papers by Paul E. Van Schil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Van Schil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Van Schil. The network helps show where Paul E. Van Schil may publish in the future.

Co-authorship network of co-authors of Paul E. Van Schil

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Van Schil. A scholar is included among the top collaborators of Paul E. Van Schil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Van Schil. Paul E. Van Schil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	175TiP: ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC 2025 ·Journal of Thoracic Oncology ·(unknown), (unknown), Paul E. Van Schil, (unknown), (unknown), (unknown), M. Pérol, (unknown), Kersti Oselin, (unknown), Heidi Roschitzki‐Voser, Eva Grolimund, Barbara Ruepp, Urania Dafni, (unknown), Solange Peters	1
2	From Macroscopy to Ultrastructure: An Integrative Approach to Pulmonary Pathology 2022 ·Frontiers in Medicine ·Stijn E. Verleden, Peter Braubach, Christopher Werlein, (unknown), Mark Kühnel, Annemiek Snoeckx, (unknown), Tobias Welte, Axel Haverich, Florian Laenger, (unknown), Patrick Pauwels, (unknown), Paul E. Van Schil, Thérèse Lapperre, Johanna M. Kwakkel‐van Erp, Maximilian Ackermann, Jeroen Hendriks, Danny Jonigk	2
3	Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, China 2022 ·Translational Lung Cancer Research ·Jiagen Li, Fengwei Tan, Yalong Wang, Qi Xue, Yushun Gao, Juwei Mu, Yousheng Mao, Jun Zhao, Dali Wang, (unknown), Susheng Shi, Kenichi Suda, Giuseppe Cardillo, Luca Bertolaccini, Maurizio Infante, Paul E. Van Schil, Shugeng Gao, Jie He	10
4	Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis 2021 ·Translational Lung Cancer Research ·Yang Liu, Sen Yang, Jiuzhou Zhao, Zhen He, Jie Ma, Yongjun Guo, Wei Wang, Akihiko Yoshizawa, Arsela Prelaj, Marcello Tiseo, Nicola Normanno, Paul E. Van Schil, Qiming Wang, Xiaopeng Yang	15
5	Radiologic-Pathologic Correlation in Lung Cancer Presenting as a Subsolid Nodule: Room for Improvement? 2017 ·Annemie Snoeckx, (unknown), Patrick Pauwels, Paul E. Van Schil, Maarten Spinhoven, Paul M. Parizel, Jan P. van Meerbeeck	2
6	Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(aEuro) 2015 ·Annals of Oncology ·Paul Baas, (unknown), K.M. Kerr, Paul E. Van Schil, Rick L. Haas, Sarah B. Peters, (unknown)	3
7	Sarcomatous Degeneration in Fibrous Dysplasia of the Rib Cage 2013 ·The Annals of Thoracic Surgery ·(unknown), Patrick Pauwels, Johan Somville, (unknown), (unknown), Paul E. Van Schil	5
8	A second mediastinoscopy: how to decide and how to do it?☆ 2008 ·European Journal of Cardio-Thoracic Surgery ·Paul E. Van Schil, Michèle De Waele	8
9	Giant Calcified Bulla Compressing the Mediastinum 2007 ·Respiration ·Maria Letizia Vita, (unknown), (unknown), Jeroen Hendriks, Patrick Lauwers, Paul E. Van Schil	2
10	Closure of the Cribriform Fascia: An Efficient Anatomical Barrier Against Postoperative Neovascularisation at the Saphenofemoral Junction? A Prospective Study 2007 ·European Journal of Vascular and Endovascular Surgery ·Marianne De Maeseneer, Tine Philipsen, (unknown), Patrick Lauwers, Jeroen Hendriks, Stefan De Hert, Paul E. Van Schil	32
11	Early and late complications of silicone patch saphenoplasty at the saphenofemoral junction 2006 ·Journal of Vascular Surgery ·Marianne De Maeseneer, (unknown), Patrick Lauwers, Jeroen Hendriks, Stefan De Hert, Paul E. Van Schil	15
12	Accuracy of Duplex Evaluation One Year after Varicose Vein Surgery to Predict Recurrence at the Sapheno–Femoral Junction after Five Years 2005 ·European Journal of Vascular and Endovascular Surgery ·Marianne De Maeseneer, (unknown), Jeroen Hendriks, Patrick Lauwers, Paul E. Van Schil	50
13	Current management of spontaneous pneumothorax 2005 ·Monaldi Archives for Chest Disease ·Paul E. Van Schil, Jeroen Hendriks, Marianne De Maeseneer, Patrick Lauwers	8
14	Silicone patch saphenoplasty to prevent repeat recurrence after surgery to treat recurrent saphenofemoral incompetence: long-term follow-up study 2004 ·Journal of Vascular Surgery ·Marianne De Maeseneer, (unknown), Paul E. Van Schil	40
15	Can Interposition of a Silicone Implant After Sapheno-femoral Ligation Prevent Recurrent Varicose Veins? 2002 ·European Journal of Vascular and Endovascular Surgery ·Marianne De Maeseneer, (unknown), Paul E. Van Schil, Stefan De Hert	27
16	Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer After a Response to Induction Chemotherapy: EORTC 08941 2000 ·Clinical Lung Cancer ·Ted A.W. Splinter, Paul E. Van Schil, G. Kramer, Jan P. van Meerbeeck, A. Gregor, P Rocmans, A. Kirkpatrick	21
17	Clinical Relevance of Neovascularisation on Duplex Ultrasound in the Long-Term Follow-up after Varicose Vein Operation 1999 ·Phlebology The Journal of Venous Disease ·Marianne De Maeseneer, Ignace F.J. Tielliu, Paul E. Van Schil, Stefan De Hert, E Eyskens	11
18	Long-term survival after bronchial sleeve resection: Univariate and multivariate analyses 1996 ·The Annals of Thoracic Surgery ·Paul E. Van Schil, Aart Brutel de la Rivière, Paul J. Knaepen, (unknown), (unknown), Dominique Goossens, Roland G.J.R.A. Vanderschueren, Jules M. van den Bosch	51
19	Completion pneumonectomy after bronchial sleeve resection: Incidence, indications, and results 1992 ·The Annals of Thoracic Surgery ·Paul E. Van Schil, Aart Brutel de la Rivière, Paul J. Knaepen, Henry A. van Swieten, J. Defauw, Jules M. van den Bosch	30
20	Hypoxic ventilatory response and carotid endarterectomy 1992 ·European Journal of Vascular Surgery ·R. Vanmaele, Wilfried A. De Backer, Marc Willemen, Paul E. Van Schil, Marianne De Maeseneer, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact